Stiefel Laboratories, Inc. Successfully Completes Tender Offer for Shares of Barrier Therapeutics, Inc.
August 05, 2008 09:05 ET
|
Barrier Therapeutics, Inc.
PRINCETON, N.J., Aug. 5, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. ("Barrier Therapeutics") (Nasdaq:BTRX), a pharmaceutical company that develops and markets dermatology products, announced...
Barrier Therapeutics, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period Relating to the Stiefel Laboratories, Inc. Proposal to Acquire Barrier Therapeutics, Inc.
July 29, 2008 09:23 ET
|
Barrier Therapeutics, Inc.
PRINCETON, N.J., July 29, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. ("Barrier Therapeutics") (Nasdaq:BTRX), a pharmaceutical company that develops and markets dermatology products, today...
Barrier Therapeutics, Inc. and Stiefel Laboratories, Inc. Sign Definitive Merger Agreement
June 23, 2008 09:00 ET
|
Barrier Therapeutics, Inc.
PRINCETON, N.J., June 23, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. ("Barrier Therapeutics") (Nasdaq:BTRX), a pharmaceutical company that develops and markets dermatology products, today...
Barrier Therapeutics Announces Agreement with Procter & Gamble to Market Xolegel (ketoconazole, USP) Gel, 2 Percent With Head & Shoulders Shampoo as Xolegel Duo
May 22, 2008 07:30 ET
|
Barrier Therapeutics, Inc.
PRINCETON, N.J., May 22, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company developing and commercializing products in the field of therapeutic dermatology,...
Barrier Therapeutics Announces First Quarter 2008 Financial Results
April 29, 2008 16:00 ET
|
Barrier Therapeutics, Inc.
PRINCETON, N.J., April 29, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company that develops and markets dermatology products, today announced its financial...
Barrier Therapeutics to Present At the Deutsche Bank 33rd Annual Health Care Conference
April 28, 2008 07:30 ET
|
Barrier Therapeutics, Inc.
PRINCETON, N.J., April 28, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company that develops and markets dermatology products, today announced that executive...
Barrier Therapeutics to Release First Quarter 2008 Financial Results on April 29, 2008
April 22, 2008 07:39 ET
|
Barrier Therapeutics, Inc.
PRINCETON, N.J., April 22, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, will release...
Barrier Therapeutics Announces Positive Results in Reducing Itch Symptoms With Novel Oral Antihistamine Agent Hivenyl
April 09, 2008 07:20 ET
|
Barrier Therapeutics, Inc.
PRINCETON, N.J., April 9, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, today...
Barrier Therapeutics Granted Second Interim Patent Term Extension for Vusion Ointment
March 24, 2008 13:04 ET
|
Barrier Therapeutics, Inc.
PRINCETON, N.J., March 24, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, announced...
Barrier Therapeutics Announces Chief Financial Officer Succession
March 17, 2008 16:30 ET
|
Barrier Therapeutics, Inc.
PRINCETON, N.J., March 17, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX) announced today that Dennis P. Reilly, Vice President of Finance and Principal Accounting Officer of the...